ROP · Roper Technologies Inc
Price
Snapshot
50 fields · last close| Market Cap | $37.85B |
| P/E | 15.11 |
| Float | 98.51M |
| Beta | 0.72 |
| Volatility | 18.0% |
| Exchange | NASDAQ |
| Sector | Technology |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 80.6 |
| Price | 382.59 |
| Change | −0.03% |
| Prev Close | 382.71 |
| Open | 387.17 |
| Day Low | 378.82 |
| Day High | 391.01 |
| Avg Vol | 1 |
| Avg $ Vol | $249.4M |
| 52W High | 519.10 |
| 52W Low | 305.96 |
| 52W Pos | 36.0% |
| From High | −26.30% |
| From Low | +25.05% |
| Max DD 1Y | −38.67% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +5.19% |
| SMA 50 | −1.04% |
| SMA 200 | +4.78% |
| RSI (14) | 58.7 |
| Vol 30D | 27.0% |
| Vol 90D | 31.1% |
| 1Y Range | 306–519 |
| Daily bars | 536 |
| Perf Week | +5.11% |
| Perf Month | +2.12% |
| Perf Quarter | +5.48% |
| Perf Half Y | +5.59% |
| Perf Year | −23.42% |
| Perf YTD | −11.96% |
| Prev Day | −0.03% |
| Clavix | B+ |
| Debt / Eq | 0.47 |
| Curr Ratio | 0.52 |
| Int Cover | 7.5× |
| FCF Margin | 32.1% |
| Rev Growth | +12.3% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 3 / 100 |
What ROP does
Roper Technologies, Inc. designs and develops vertical software and technology enabled products in the United States, Canada, Europe, Asia, and internationally.
Its Application Software segment offers comprehensive management, diagnostic and laboratory information management, enterprise software and information solutions, K-12 school administration, transportation management, financial and compliance management, cloud-based and integrated payment processing, campus technology and payment, and cloud-based financial analytics, performance management software, and data solutions; cloud-based software for the property and casualty insurance industry; and foodservice technologies.
The Network Software segment provides cloud-based data, collaboration, and estimating automation software; electronic marketplace; visual effects and 3D content software; cloud-based software and AI-enabled analytics solutions for the life insurance and financial services industries; supply chain software; health care services and software; data analytics and information; pharmacy software solutions; and AI-enabled SaaS providing digital engagement, as well as church management and integrated giving solutions for faith-based organizations.
The Technology Enabled Products segment offers ultrasound procedures accessories; dispensers and metering pumps; wireless sensor network and solutions; automated surgical scrub and linen dispensing equipment; water meters; optical and electromagnetic precision measurement systems; RFID card and credential readers; and medical devices.
It distributes and sells its products through direct sales offices, manufacturers’ representatives, resellers, and distributors.
The company was formerly known as Roper Industries, Inc. and changed its name to Roper Technologies, Inc. in April 2015.
Roper Technologies, Inc. was incorporated in 1981 and is based in Sarasota, Florida.
Clavix risk grade
regraded every trading dayROP grades B+, 80.6 of 100. Steadiest on Sector Resilience (80), most exposed on Price Stability (62, mixed). 4 of the 4 weighted dimensions sit above the Technology median. Ranks 3 of 100 in Technology by Clavix score.
How rough the ride is
| ROP | Technology median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.72 | 1.29 |
| Volatilityannualized | 18.0% | 32.7% |
| Max drawdown, past yearworst peak-to-trough fall | −38.7% | — |
| Typical daily movemedian absolute daily change | 0.83% | — |
| Days beyond ±3%of the last 252 sessions | 26 (10%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| ROP | Technology median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.72 | 1.29 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 39% of 102 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Technology names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| ROP | |
|---|---|
| 1 week | +5.1% |
| 1 month | +2.1% |
| Year to date | −12.0% |
| 1 year | −23.4% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| ROP | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 6 Aug |
| Average score0 most bearish, 100 most bullish | 70 |
| Bullish · bearisharticles above 60 · below 40 | 26 · 0 |
| Directionarticles whose tone is improving vs worsening | 26 ↑ 0 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 100 Technology names Clavix covers; the tick is the sector median.
Growth
| ROP | |
|---|---|
| Revenue growthyear over year | +12.3% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Technology median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openRoche has signed an exclusive global licensing deal with Rona Therapeutics for an RNA interference (RNAi) drug that targets a protein called ALK7, aimed at treating obesity by reducing belly fat while preserving muscle mass.
Roche's Genentech unit reported Phase III trial results for vamikibart, a drug for uveitic macular edema (eye swelling that can cause vision loss). The FDA has accepted the application to approve the drug, with a decision expected in 2027.
Frontline Education and AI for Education won two Tech & Learning Best for Back to School Awards, recognized in both Primary and Secondary education categories. The article body is too short to provide further details.
Roche Diagnostics sent two molecular testing instruments to help with the Ebola response in the Democratic Republic of Congo. The article notes Roche shares recently traded at CHF 352.70, down 2.03% that day, but up 4.78% over 90 days and 23.81% over one year.
Roper Technologies added Abhijit Dubey, the CEO and Chief AI Officer of NTT DATA, to its Board of Directors for a term running through the 2027 Annual Meeting of Stockholders, bringing cloud and AI expertise to its governance. The company also expanded its share buyback program and raised its revenue forecast, which it backed by recurring software revenue.
Nearest peers by size
Technology| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| TWLO | Twilio Inc | D+ | $37.53B | 32.67 | 1.47 | Compare |
| NTAP | NetApp Inc | C+ | $40.03B | 28.23 | 1.52 | Compare |
| P | Everpure Inc | D+ | $41.32B | 163.15 | 1.44 | Compare |
| CRWV | CoreWeave Inc | F | $33.86B | — | 3.20 | Compare |
| OKTA | Okta Inc | C- | $32.74B | 110.60 | 0.72 | Compare |
| NBIS | Nebius Group NV | F | $44.98B | 1,060.94 | 1.13 | Compare |
| WDAY | Workday Inc | C+ | $47.39B | 37.88 | 1.03 | Compare |
| CTSH | Cognizant Technology Solutions Corp | B | $29.74B | 13.40 | 0.86 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.